Program Details

Buffalo, NY
Job Address: Khurshid Guru, M.D., Endourology Fellowship Director Roswell Park Comprehensive Cancer Center Elm and Carlton Streets Buffalo, NY 14263
Contact Name: Nancy Sikora, Fellowship Coordinator
Type/Focus: Robotic Surgery & Minimally Invasive Urologic Oncology
Duration: 2 Years
Country: United States
Phone: 716-845-3389
Fax: 716-845-3300
Region: North America
Contact Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

The clinical fellowship program at RPCI began in 1982 and became accredited by the Endourologic Society in 2018. Fellows receive training in basic/translational research by conducting research with faculty in the Department of Urology. An affiliation agreement with the State University of New York at Buffalo School of Medicine and Biomedical Sciences (UB) designates Roswell as the primary teaching facility in oncology for the university.

Opportunities Available

 

    • 1 Year Advanced Clinical Training Program in Laparoscopic/Robotic Surgery

 

    • 2 Year Fellowship in Laparoscopic/Robotic Surgery



The fellow spends two years training in all aspects of urologic oncology. In the first year, the fellow receives training in basic/translational research by conducting research with translational scientists in the Department of Urology or other departments at RPCI.

 

In the second year, clinical training combines training in clinical management and open, laparoscopic and robotic surgery and fellows participate in clinical research projects utilizing the prostate, bladder and kidney databases.

The Department of Urology welcomes applications from Foreign Medical Graduates (FMG). To increase the likelihood of a fruitful training experience and due to the high volume of prior applicants, Fellowship applicants should obtain a minimum USMLE Step 3 score of 200 and spend a one-to-two week rotation at RPCI during which time a formal interview will be conducted.

We perform 92% of our oncologic cases minimally invasively. We are particularly proud of our robotic cystectomy program where, for the last thirteen years, all robotic cystectomies have been performed robotically and, for the last ten years, all urinary diversions have been performed intracorporeally. Our department has a strong clinical database project that facilitates outcomes and quality of life research and meets our institutional requirement for robotic surgical quality assurance. In addition, we have a robotic training program that relies upon robotic surgical simulation and our porcine laboratory.

Our department consists of five. full-time clinicians and four full-time scientists. Fellowship applicants can choose from 1 of 6 areas of scientific study for a research experience conducive to a successful academic career: 1) molecular & cellular biology, 2) immunology, 3) genetics, 4) pharmacology & experimental therapeutics, 5) cancer prevention and epidemiology, or 6) quality of life/outcomes.

Overview

Roswell Park Comprehensive Cancer Center was the first research laboratory in the world to focus exclusively on cancer. Established in 1898 by eminent American surgeon Dr. Roswell Park, it expanded in 1913 with the opening of a cancer hospital. By uniting research and clinical care, the Institute became a model for speeding the transfer of knowledge from the laboratory to the patient’s bedside.

Today Roswell Park is a freestanding cancer center that employs more than 3,200 people, including 299 faculty members whose work encompasses patient care, research, and education. The Institute is one of only 49 National Cancer Institute-designated comprehensive cancer centers in the nation. Roswell Park is also a member of the National Comprehensive Cancer Network (NCCN), an alliance of leading cancer centers that work together toward continuous quality improvement and the creation of evidence-based practice guidelines.

Among other distinctions:

 

    • We are home to one of the largest early-phase clinical trials programs

 

 

    • The Institute is set in the heart of the Buffalo Niagara Medical Campus (BNMC), placing physicians in an exciting environment that encourages and supports collaboration and innovation in clinical care and research. Roswell Park is just steps away from the new John R. Oishei Children’s Hospital and the Jacobs School of Medicine and Biomedical Sciences of the University at Buffalo, both opening in 2017, as well as the Hauptman-Woodward Medical Research Institute and the New York State Center of Excellence in Bioinformatics and Life Sciences. The BNMC is a rapidly evolving incubator for biotech start-ups.

 

    • Roswell Park’s Center for Immunotherapy is equipped with a cGMP Therapeutic Cell Production Facility, Immune Analysis Facility, and Vector Development & Production Facility, and is capable of taking a drug from development to clinical trials all in one location.

 

    • Roswell Park developed the prostate-specific antigen (PSA) test and photodynamic therapy (PDT), and made significant contributions to the Human Genome Project.



In every aspect of our operations, we’re guided by the Roswell Park mission: to understand, prevent, and cure cancer.

 

 Specialized Treatments and Therapies

The clinical case mix at Roswell Park is varied, with site-specific data for 30 cancer sites recorded each year. Patients have access to a full range of diagnostic and treatment services, including therapies not available elsewhere in the region.

Specialized treatments include:

 

    • Robot-Assisted Surgery

 

    • Immunotherapy

 

    • Photodynamic Therapy

 

    • High-Dose Chemotherapy



A Focus on Translational Research

 

Through research, clinical fellows at Roswell Park become partners in elevating the standard of oncology care. Our clinical fellows enjoy caseloads that allow the time and opportunity to pursue clinical or basic research, attend seminars, study, and write papers. Close interaction with basic scientists provides fertile ground for engaging in basic, applied, and clinical research.

The Institute’s 20 world-class shared resources include flow cytometry, small-molecule screening, translational imaging, and the Data Bank and BioRepository, which prospectively collects and provides de-identified biospecimens and associated epidemiological and clinical data to investigators with IRB-approved protocols.

Endourology Society Requirements:

The fellow must fulfill all of the responsibilities of the Endourological Society fellowship including, but not limited to, preparation of a clinical case log, a published article in the Journal of Endourology, from work they performed during the fellowship with the fellow as the first author, and preparation of a manuscript for submission to the essay contest. The latter must be graded as suitable for review for possible publication in order for the fellow to receive an official diploma from the Endourology Society.  Graduation from the Roswell Park Comprehensive Cancer Center minimally invasive urology training program is contingent on obtaining Endourological Society approval.

Training, Education, Experience, and Other Requirements:

Candidates must be board eligible urologists or have recently passed the FLEX exam with application made for Urology Board eligibility.  They must also have a valid New York State medical license prior to beginning the fellowship.

San Francisco, CA
Job Address: UCSF Medical Center 400 Parnassus Avenue, Suite A-610 San Francisco, CA 94143-0330 400 Parnassus Avenue, Suite A-610 San Francisco, CA 94143-0330
Contact Name: Marshall Stoller, M.D., David Bayne, MD, MPH, Coordinator: Katherine Jung
Type/Focus: Combined
Duration: 1 or 2 Year
Country: United States
Phone: 415-885-7748
Fax: 415-476-5366
Region: North America
Contact Email: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.

Overview

The Endourology Fellowship at UCSF under the joint direction of Drs. Marshall Stoller and David Bayne, aims to train innovative, superb clinicians and researchers and provide them with the tools to pursue careers in academic urology and research. The program seeks to attract bright, committed, and compassionate applicants from diverse backgrounds, who aspire to become future leaders in this specialty. The program has trained fellows since 1989 and was accredited by the Endourological Society starting in 2018. The recruitment goal of the training program is to recruit one fellow each for a one-year training program. The endourology faculty at UCSF includes Drs. Marshall Stoller, David Bayne, Justin Ahn, Max Bowman, David Tzou, and Kyle Spradling. The fellow will work with the faculty to develop an individualized training curriculum that is tailored to the fellow’s career goals and adherent to fellowship certification standards of the Endourology Society.

Clinical Training Opportunities

The fellows’ clinical training includes exposure to all aspects of medical treatment of urinary stone disease, surgical endourologic techniques, and mastery of laparoscopic and minimally invasive surgery before completing their fellowship. Graduating fellows will be proficient in both fluoroscopic and ultrasound guided percutaneous renal access techniques from both the supine and prone positions. They also will gain proficiency in advanced ureteroscopy and holmium laser enucleation of the prostate (HoLEP) as well as robotic surgery and advanced laparoscopy. In one year, fellows typically complete >100 URS, >50 PCNL, >50 HoLEP and >20 laparoscopy/robotic cases. 

Research Training Opportunities

For the research aspect of fellowship training, fellows are exposed to a broad range of basic, clinical, and translational research work. They have ample opportunity to be productive, publishing manuscripts as well as presenting their findings at national and regional scientific meetings. Their training will include mastering strategies to optimize study design and the basics of grantsmanship.

Multiple federally funded projects are currently ongoing that provide fellows with a vast array of areas on which to focus, whether it be clinical, basic, translational, or device development research. Dr. Stoller’s NIH funded LAUNCH Program (Laboratory for Accelerated Urinary Stone Care and Health Innovation) provides fellows with broad access to cutting-edge translational platforms—including papillary imaging, Drosophila stone modeling, and advanced tissue and biomarker analysis. Through LAUNCH, fellows have the opportunity to participate in or lead projects in early-stage discovery science, device development, pilot clinical protocols, and multidisciplinary collaborations that span basic science, engineering, and industry. The program’s infrastructure supports fellows in generating preliminary data, developing pilot studies, and shaping ideas into fundable research trajectories. Dr. Bayne leads an NIH funded career development grant through which fellows will have the opportunity to collaborate in health services research and clinical trial design, as well as international projects in global urological surgery training and infrastructure development in Sub Saharan Africa and the Caribbean.

Based on their individual interests, fellows select a primary research focus that serves as a foundation for building long-term investigative skills. Training includes protocol development, device design, laboratory technique acquisition, performance of experiments, clinical data management, and preparation of manuscripts and national meeting presentations. Fellows are expected to publish in peer-reviewed journals and present at regional, national, and international scientific forums.

This combined approach to fellowship training utilizing both rich clinical and research experiences will provide graduating fellows with the tools to pursue long and productive careers in endourology.

Vancouver, B.C.
Job Address: Stone Centre at Vancouver General Hospital/University of British Columbia Jim Pattison Pavilion 899 12th Avenue W Vancouver, B.C. V52 1M9
Contact Name: Connor Forbes, MD
Type/Focus: Endourology
Duration: 2 Years
Country: Canada
Region: North America
Contact Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Overview:

The goal of this unique fellowship is to provide top-tiered training in both clinical and research aspects around kidney stone disease. Under the leadership of Connor Forbes, MD Ryan Paterson, MD, Ben Chew, MD, and Dirk Lange, PhD, the candidate will be well-positioned to receive expert training both clinically and academically. This will yield an academically oriented endourologist who will make significant future clinical and research contributions to endourology. By involving the fellow in our current research program pertaining to ureteral stent development, biomaterials, stone fragmentation, and the pathophysiology of kidney stone development/prevention, the fellow will receive training on how to develop and answer important research questions using a translational approach, to ultimately improve the way that we treat kidney stones.

The fellow will be directly involved with teaching local courses for visiting urologists, resident trainees and contribute to future industry-led educational activities and expert panel discussions. In preparation of being a future thought leader in endourology, the fellow will be given opportunities to talk at international meetings. This along with their introduction to various industry contacts will allow the fellow to develop key collaborations with industry and research leaders on the development of devices and new methods for the treatment of stone disease.  To achieve these goals, the fellows 2-year fellowship will be split approximately 50% research and 50% clinical responsibilities.

 

Key Faculty:

Dr Connor Forbes, MD, FRCSC (Fellowship Director): Having trained at Vanderbilt under Drs. Nicole Miller and Ryan Hsi, Dr. Forbes specializes in Endourology/Minimally Invasive Surgery with a special focus on BPH, Kidney Stones, and upper tract minimally invasive surgery. He is an Assistant Professor at the University of British Columbia. His practice is composed of approximately 40% BPH and 40% kidney stones. Surgically, he offers both prone and supine endoscopic, ultrasound, and fluoroscopic guided PCNL and HoLEP. While not the primary focus of the program, fellows may have the opportunity to attend select robotic/MIS procedures. From a research perspective, Dr Forbes is involved with BPH and kidney stone trials, and laboratory investigation of BPH mechanisms.

 

Ryan F. Paterson, MD, FRCSC: is an endourologist who spends approximately 70% of his time treating and managing patients with kidney stones.  A fellowship trained endourologist from Dr. Jim Lingeman at Indiana University, Dr. Paterson provides excellent clinical care of patients with stones as well as BPH, being one of a handful of urologists in Canada who is adept at the HoLEP procedure.  The fellow will spend time with Dr. Paterson learning clinical and surgical management of stones including percutaneous nephrolithotomy, ureteroscopy, shockwave lithotripsy, and metabolic management.

 

Ben Chew, MD, MSc, FRCSC: Ninety percent (90%) of his practice involves the treatment of kidney stones and 35% of his time is dedicated to research—both basic and clinical.

Dirk Lange, PhD is the Director of Basic Science Research at the Stone Centre at Vancouver General Hospital. One research area focuses on ureteral peristalsis and smooth muscle function and how these are impacted by inflammation due to indwelling stents.  No one else has examined the specific molecular mechanisms involved, and research outcomes will identify targets to prevent ureteral stent-related problems and improve their overall function.  A microbiologist by training, he is well recognized for his work in biomaterials in medicine, specifically pertaining to the prevention of indwelling device-associated infections. His project on the role of the intestinal microbiome in kidney stone formation is unique, having identified specific bacterial metabolites that prevent crystal formation and deposition in the kidneys.  Together with our clinical team, they form a unique translational team not found elsewhere in North America.  Dr. Lange will oversee the basic science research aspect of the fellow’s training, which we believe to be an important characteristic of a future clinical and academic leader.

Training Program Focus:

The program will focus on endourology, specifically kidney stones and BPH. During the fellowship, the trainee will be educated in the medical management of stones including seeing patients in the Stone Clinic. Therefore, the fellow will receive training in both surgical and metabolic aspects of managing kidney stone disease, both of which are important for a comprehensive treatment regime.

Surgical experience will consist of learning shockwave lithotripsy (SWL), ureteroscopy, percutaneous nephrolithotomy (PCNL) and Holmium and Thulium Laser enucleation of the prostate (HoLEP/ThuLEP).  Scheduling of this will include 2.5 days per week of clinical work with the split as follows: 

    • 0.5 days/week seeing patients in clinic
    • 2 days/ week performing procedures with Dr Ben Chew, Dr Ryan Paterson, and Dr Connor Forbes

The remaining 2.5 days per week will be spent on research in both the basic science laboratory as well as clinical research.

    • 0.5 days/week working on database clinical research with our Clinical Research Coordinator/Manager developing and learning IRB protocols
    • 1 day/week in the laboratory with Dr. Dirk Lange learning microbiology techniques, biomaterials, and DNA sequencing for metagenomic projects
    • 1 additional day/week of research which can be either clinical or basic science, depending on the fellow's particular goals
    • The split will be 50% research and 50% clinical activity for each of the 2 years of the fellowship.

Research Focus:

The Stone Centre is a world class centre within the UBC Department of Urologic Sciences. In addition to high volume delivery of patient care, under the leadership of Dr Ben Chew, Dr Dirk Lange, and Dr Ryan Paterson the centre is a model for successful investigator initiated inquiry and industry partnerships. The existing research infrastructure includes research associates and graduate/undergraduate students. Each year, the centre has a large number of clinical trials, clinical research projects, and basic science research projects ongoing.

The successful fellow will use the expertise from this centre to acquire the skills needed for an independent research career. We encourage applications with post-fellowship academic goals in the area of Endourology. Fellows are responsible for participating in the large, longitudinal clinical trials that are ongoing to understand how to integrate these into a future academic practice. In addition, the fellow will select several smaller, ideally self-driven projects of interest and see these through to fruition, including manuscript preparation.

Clinician researchers with expertise in basic science research techniques are rare in our field, and our unique program will graduate fellows with the basic knowledge required to begin their own translational program. Teaching the principles and mechanics of how to do research from beginning to end will be very important for their development.

Towards the end of the fellowship, we expect the trainee to have collected enough data to present at national and international meetings and to prepare and publish peer-reviewed manuscripts. The fellow, upon graduation, will receive a designation and certificate from the Endourology Society.

Chicago, IL
Job Address: University of Chicago, Section of Urology 5841 S. Maryland Ave.-MC6038 Chicago, IL 60637
Contact Name: Arieh Shalhav, M.D.
Type/Focus: Laparoscopy & Robotics
Duration: 2 Years
Country: United States
Phone: (773)702-9757
Fax: (773)702-1001
Region: North America
Contact Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

The University of Chicago Medical Center

EndoUrology Fellowship Program

 

Name of the Host Institution: The University of Chicago Medicine

Program Subspecialty: Minimally Invasive Urologic Oncology, Pediatric Urology and Reconstruction

 

Director:       Arieh L. Shalhav, MD     This email address is being protected from spambots. You need JavaScript enabled to view it.

Coordinator  Joanne Swanson       This email address is being protected from spambots. You need JavaScript enabled to view it.

  

Faculty:                     Mohan Gundeti, MD                                                           

                                   Scott Eggener, MD

                                   Gregory P. Zagaja, MD

                                   Greg Bales MD

                                   Sara Faris MD

 

PLEASE NOTE:  THE UNIVERSITY OF CHICAGO IS NOT PARTICIPATING IN THE 2022 FELLOWSHIP MATCH

Program overview

With large surgical volumes, prospective databases, animal and translational labs and outcomes research support, the EndoUrological Society (EUS) fellowship at the Section of Urology at the University of Chicago will commence on July 2018. Clinically, the two year EUS fellowship will include major experience with Robotic/laparoscopic Urologic Oncology and minor experiences with Robotic/laparoscopic Pediatric Urology and Reconstructive Urology. Research during the two year EUS fellowship will be tailored to the fellow’s interests - robotic animal or simulation lab, translational or outcomes research. Research planning will start immediately after the match. Fellows will participate and present their work in national and international meetings. Graduation will be conditional based on achievement of clinical autonomy and authorship of a minimum of four papers.

 

Prerequisite:

The candidate must have completed an ACGME-accredited or foreign urologic training program. Three recommendation letters from previous mentors. A valid license to practice medicine in the State of Illinois is essential. The candidate must also be fluent in reading, writing, and conversing in English. Previous robotic/laparoscopic skills and experience with manuscript writing and publication, as well as statistical analysis is advantageous.

Clinical Expectation and Surgical Volume:

Clinical responsibilities include perioperative patient management, data collection for analysis and presentation. Clinic will take place 1 day/week. Aside from research projects, a significant component of daily activities will include operative experience. The fellow will be involved in a high number of surgeries. The fellow will not be expected to cover call, except on rare occasions. The resident team will specifically be responsible for patient rounding.

Our institution owns six clinical robotic systems (2 XI, 2 X and 2 SI) and one-research SI

Yearly case volumes include:

Robotic prostatectomy 350 cases/year
Robotic/Laparoscopic partial nephrectomy 100 cases/year
Robotic/Laparoscopic radical nephrectomy   50 cases/year
Robotic/Laparoscopic ablative techniques    25 cases/year
Robotic/Laparoscopic radical cystectomy    20 cases/year
Robotic/Laparoscopic RPLND    12 cases/year
Robotic/Laparoscopic pediatric procedures    40 cases/year
Robotic/Laparoscopic reconstructive procedures    40 cases/year

Paris, France
Job Address: Hospital Tenon 4 rue de la Chine- Paris 20e 75020 Paris, France.
Contact Name: Pr. Olivier Traxer
Type/Focus: Endourology
Duration: 1 Year
Country: France
Phone: 0156016153
Region: Europe
Contact Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

One year endourology fellowship for stone and urothelial tumor surgery.

The fellowship consists on both surgery and research.

Stone management is completely covered including metabolic evaluation (in specific stone clinics) and laboratory stone analysis directed by Pr. Michel Daudon and Pr. Jean Philippe Haymann.

Stone treatment is fully covered with PCNL, SWL and mainly focused on developing the flexible ureteroscopy technique with more than 1000 procedures per year. We also concentrate on laser treatment of lower and upper urinary tract tumors and BPH (specially Holmium prostate enucleation, green light laser vaporization and bipolar resection).

We preform all kinds of clinical and laboratory studies for both stone and upper tract tumor management including in-vitro research (with a fully equipped arsenal with all kinds of lasers, ureteroscopes and endourological material), diverse trials for new equipment in endourology, tests in cadaveric models and studies in the university’s engineering laboratory for laser energetics with the collaboration of their complete staff.

Please be aware that the department cannot provide a salary and that you should ensure your own funding.

Contact name: Director: Pr. Olivier Traxer M.D . Co-Director: Pr. Jean Philippe Haymann M.D.

More Articles …

  1. Loyola University Medical Center
  2. Urology & Nephrology Center, Mansoura Egypt
  3. Cristo Re Hospital - Rome, Italy
  4. Wisconsin Endourology Fellowship
Page 11 of 26